Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 15001-15050 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03910452
Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide
EARLY_PHASE1Active, not recruiting
4 participants
Started: Oct 28, 2019 · Completed: Jun 15, 2034
1 condition1 sponsor1 location
NCT04096443
Oral FMT (Fecal Microbial Transplant) in Subjects with Multiple Sclerosis
EARLY_PHASE1Active, not recruiting
9 participants
Started: Oct 28, 2019 · Completed: Dec 30, 2024
1 condition2 sponsors1 location
NCT04499534
BRCA1/2 Flu Vaccine
N/AActive, not recruiting
50 participants
Started: Oct 28, 2019 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT04069754
Passport to Freedom (P2F): Adaptation and Implementation of a Wellness Program
NAActive, not recruiting
40 participants
Started: Oct 28, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03768570
Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
PHASE2Active, not recruiting
82 participants
Started: Oct 25, 2019 · Completed: Mar 31, 2026
1 condition2 sponsors31 locations
NCT03834961
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia
PHASE2Active, not recruiting
31 participants
Started: Oct 25, 2019 · Completed: Mar 25, 2026
5 conditions2 sponsors80 locations
NCT04101084
Rocking Chair Therapy in Elderly With Dementia: Its Effects on Agitation
NAActive, not recruiting
12 participants
Started: Oct 25, 2019 · Completed: Apr 18, 2024
1 condition1 sponsor1 location
NCT04777045
Efficacy of Diltiazem to Improve Coronary Microvascular Dysfunction: a Randomized Clinical Trial
PHASE3Active, not recruiting
85 participants
Started: Oct 25, 2019 · Completed: Dec 31, 2026
3 conditions1 sponsor3 locations
NCT04341571
Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.
PHASE2Active, not recruiting
30 participants
Started: Oct 24, 2019 · Completed: Jul 31, 2025
4 conditions1 sponsor1 location
NCT03995108
Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) Syndrome
PHASE3Active, not recruiting
31 participants
Started: Oct 24, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor23 locations
NCT03924661
SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy
N/AActive, not recruiting
20 participants
Started: Oct 24, 2019 · Completed: Oct 31, 2028
1 condition1 sponsor13 locations
NCT05730647
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients
N/AActive, not recruiting
600 participants
Started: Oct 24, 2019 · Completed: Jul 31, 2032
1 condition1 sponsor40 locations
NCT04016402
Imaging to Improve Brain Stimulation
N/AActive, not recruiting
42 participants
Started: Oct 24, 2019 · Completed: Dec 31, 2025
1 condition3 sponsors2 locations
NCT04052880
Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM
PHASE2Active, not recruiting
17 participants
Started: Oct 24, 2019 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT04101630
Activity Monitoring in Pulmonary Hypertension
N/AActive, not recruiting
230 participants
Started: Oct 24, 2019 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT04616963
Emtricitabine/Tenofovir Alafenamide Switch Study for Transgender Individuals for HIV Pre-exposure Prophylaxis
PHASE4Active, not recruiting
64 participants
Started: Oct 24, 2019 · Completed: Jan 31, 2024
2 conditions1 sponsor1 location
NCT04085510
Tomosynthesis Vs. Contrast-Enhanced Mammography in Women with Personal History of Breast Cancer in Western Pennsylvania
NAActive, not recruiting
1,647 participants
Started: Oct 23, 2019 · Completed: Jun 30, 2027
4 conditions2 sponsors3 locations
NCT04006262
Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma.
PHASE2Active, not recruiting
32 participants
Started: Oct 23, 2019 · Completed: Oct 31, 2025
2 conditions2 sponsors15 locations
NCT03870919
Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients
NAActive, not recruiting
200 participants
Started: Oct 23, 2019 · Completed: Oct 23, 2027
3 conditions2 sponsors26 locations
NCT04111939
HEALing Communities Study
NAActive, not recruiting
67 participants
Started: Oct 23, 2019 · Completed: Sep 30, 2025
1 condition7 sponsors4 locations
NCT04017455
Neoadjuvant Treatment in Rectal Cancer With Radiotherapy Followed by Atezolizumab and Bevacizumab (TARZAN)
PHASE2Active, not recruiting
38 participants
Started: Oct 22, 2019 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT06475625
Clinical Impact of Orsiro™ Stent in Patient With Chronic Kidney Disease
PHASE4Active, not recruiting
3,113 participants
Started: Oct 22, 2019 · Completed: Jan 1, 2027
2 conditions1 sponsor1 location
NCT03984448
Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
PHASE2/PHASE3Active, not recruiting
363 participants
Started: Oct 22, 2019 · Completed: Apr 1, 2028
8 conditions1 sponsor636 locations
NCT06136286
ORIF Distal Radius Blood Flow Restriction Therapy
NAActive, not recruiting
70 participants
Started: Oct 22, 2019 · Completed: Jan 1, 2027
1 condition1 sponsor1 location
NCT04132505
Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer
PHASE1Active, not recruiting
39 participants
Started: Oct 22, 2019 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT04797403
Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline
NAActive, not recruiting
1,306 participants
Started: Oct 22, 2019 · Completed: Aug 31, 2026
2 conditions3 sponsors1 location
NCT03932201
Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
N/AActive, not recruiting
371 participants
Started: Oct 21, 2019 · Completed: Mar 31, 2027
1 condition1 sponsor29 locations
NCT04074733
Diagnostic Performance of the Ultra Low-Dose (ULD) Scanner vs. Diagnostic Performance With Standard X-rays in the Emergency Department Compared With Performance of the Standard Classical-dose Scanner for Trauma of the Dorsolumbar Spine, Pelvis and Extremities
N/AActive, not recruiting
554 participants
Started: Oct 21, 2019 · Completed: Sep 12, 2025
1 condition1 sponsor4 locations
NCT04592185
The Study of the Fenestrated Anaconda Device in the Treatment of Abdominal Aortic Aneurysms
N/AActive, not recruiting
106 participants
Started: Oct 21, 2019 · Completed: Oct 31, 2025
2 conditions2 sponsors33 locations
NCT04041310
Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
PHASE1/PHASE2Active, not recruiting
115 participants
Started: Oct 21, 2019 · Completed: Oct 30, 2026
1 condition2 sponsors46 locations
NCT04083781
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors
PHASE3Active, not recruiting
134 participants
Started: Oct 21, 2019 · Completed: Feb 21, 2027
2 conditions1 sponsor86 locations
NCT04090528
pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer
PHASE2Active, not recruiting
60 participants
Started: Oct 21, 2019 · Completed: Oct 31, 2026
3 conditions4 sponsors2 locations
NCT03936530
Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer
N/AActive, not recruiting
432 participants
Started: Oct 20, 2019 · Completed: Aug 1, 2026
1 condition1 sponsor1 location
NCT03784014
Molecular Profiling of Advanced Soft-tissue Sarcomas
PHASE3Active, not recruiting
603 participants
Started: Oct 19, 2019 · Completed: Oct 31, 2025
1 condition6 sponsors19 locations
NCT04124406
Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality
N/AActive, not recruiting
150,000 participants
Started: Oct 18, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03958877
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis
PHASE3Active, not recruiting
152 participants
Started: Oct 18, 2019 · Completed: May 20, 2027
1 condition1 sponsor65 locations
NCT03907631
Multi-centre Acute Severe Ulcerative Colitis Prospective Cohort Study (Elevate ASUC)
N/AActive, not recruiting
189 participants
Started: Oct 18, 2019 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT03968445
Neuroinflammation After Myocardial Infarction - Imaging Substudy
PHASE1Active, not recruiting
6 participants
Started: Oct 17, 2019 · Completed: Oct 31, 2028
1 condition1 sponsor1 location
NCT06579235
Explorative Proteomics in Pediatric Neuroborreliosis
N/AActive, not recruiting
106 participants
Started: Oct 17, 2019 · Completed: Dec 10, 2024
3 conditions3 sponsors1 location
NCT04165330
Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
PHASE1/PHASE2Active, not recruiting
56 participants
Started: Oct 17, 2019 · Completed: Mar 31, 2028
4 conditions2 sponsors1 location
NCT04036695
Arrhythmia in Hemodialysis Patients
NAActive, not recruiting
18 participants
Started: Oct 17, 2019 · Completed: Dec 30, 2025
3 conditions1 sponsor2 locations
NCT04046094
Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients
PHASE1/PHASE2Active, not recruiting
12 participants
Started: Oct 17, 2019 · Completed: Aug 31, 2026
1 condition2 sponsors3 locations
NCT03993912
Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy
PHASE3Active, not recruiting
294 participants
Started: Oct 17, 2019 · Completed: Oct 31, 2027
1 condition1 sponsor23 locations
NCT04137536
A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer
PHASE1Active, not recruiting
7 participants
Started: Oct 17, 2019 · Completed: Apr 30, 2026
4 conditions2 sponsors2 locations
NCT02203760
Pazopanib Vs. Pazopanib Plus Gemcitabine
PHASE2Active, not recruiting
58 participants
Started: Oct 16, 2019 · Completed: Dec 31, 2024
1 condition3 sponsors9 locations
NCT04088409
A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis
PHASE3Active, not recruiting
30 participants
Started: Oct 16, 2019 · Completed: Jul 31, 2028
1 condition1 sponsor20 locations
NCT03673332
Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies
PHASE4Active, not recruiting
40 participants
Started: Oct 16, 2019 · Completed: Jul 15, 2025
2 conditions2 sponsors9 locations
NCT04076813
Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry
N/AActive, not recruiting
5,050 participants
Started: Oct 16, 2019 · Completed: Jun 30, 2025
1 condition2 sponsors11 locations
NCT04151082
High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors
PHASE1/PHASE2Active, not recruiting
35 participants
Started: Oct 16, 2019 · Completed: Jul 31, 2027
3 conditions2 sponsors1 location
NCT03972072
MRI - Guided Adaptive RadioTHerapy for Reducing XerostomiA in Head and Neck Cancer (MARTHA-trial)
NAActive, not recruiting
49 participants
Started: Oct 15, 2019 · Completed: May 21, 2026
2 conditions1 sponsor1 location